Healthcare MoneyTree™ report: Q3, 2020

Start adding items to your reading lists:
Save this item to:
This item has been saved to your reading list.

PwC and CB Insights' Healthcare MoneyTree™ report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.

For full analysis of activity across all sectors, refer to the PwC/CB Insights MoneyTree™ Report.

Top five US Healthcare industries over the last five quarters:

Q3 2020 Top five US Healthcare industries over the last five quarters

Highlights for this quarter's report include, but are not limited to:

  • In the US: Funding for VC-backed Healthcare companies in US raised $8.0B in 241 deals.
  • Compared to Q2’20, the number of deals closed in Q3’20 increased by 19% from 202 to 241.
  • Of the $8.0B raised in Q3’20, $3.9B was invested in the Biotechnology subsector while $892M was invested in the Medical Devices & Equipment industry.
  • A total of $3.2B was raised this quarter through 17 mega-rounds*, making up 40% of total deal dollars raised in Q3’20.
  • In Q3’20, Silicon Valley raised $2.5B through 58 deals and is the leading region this quarter in terms of dollars raised. There were 5 mega-rounds in Silicon Valley.
  • There were 24 Healthcare IPOs in Q3’20 raising approximately $4.5B.
  • Globally: dollars invested increased to $13.8B in Q3’20, while the number of deals increased from 519 in Q2’20 to 606 in Q3’20.

Contact us

Ousmane Caba

Partner, US Pharmaceuticals and Life Sciences, PwC US

Josh Herron

US Pharmaceutical & Life Sciences Assurance Leader, PwC US

Karen C. Young

US Pharmaceutical and Life Sciences Leader, PwC US

Follow us